End Cash: The amount of cash held by the company for the given period.
IDEXX Laboratories, Inc. (IDXX) had End Cash of $397.43M for the most recently reported fiscal quarter, ending 2024-03-31.
Income Statement Financials | |
$964.10M |
|
$235.58M |
|
$371.02M |
|
$593.07M |
|
$665.14M |
|
$298.96M |
|
$-3.48M |
|
$295.48M |
|
$295.48M |
|
$235.58M |
|
$235.58M |
|
$235.58M |
|
$235.58M |
|
$298.96M |
|
$328.86M |
|
83.10M |
|
83.96M |
|
$2.84 |
|
$2.81 |
|
Balance Sheet Financials | |
$1.50B |
|
$708.73M |
|
$1.85B |
|
$3.35B |
|
$956.90M |
|
$620.78M |
|
$827.71M |
|
$1.78B |
|
$1.57B |
|
$1.04B |
|
$1.57B |
|
82.87M |
|
Cash Flow Statement Financials | |
$198.59M |
|
$-106.94M |
|
$-144.07M |
|
$453.93M |
|
End Cash |
$397.43M |
$-56.50M |
|
$14.40M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.28 |
|
0.60 |
|
61.52% |
|
31.01% |
|
31.01% |
|
-- |
|
30.65% |
|
24.44% |
|
$168.31M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.95 |
|
1.90 |
|
47.35 |
|
15.02% |
|
22.55% |
|
7.02% |
|
10.76% |
|
$18.93 |
|
$2.00 |
|
$2.37 |